Liabilities / Assets
48th percentile
Higher debt load relative to assets than 48% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.17x
Liabilities / Revenue
50th percentile
Higher debt load relative to revenue than 50% of similar nonprofits.
Net Margin
69th percentile
Higher net margin than 69% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
80th percentile
Faster asset growth than 80% of similar nonprofits.
Revenue Growth
18th percentile
Faster revenue growth than 18% of similar nonprofits.
Balance Sheet
Assets
Up$2,699,793
Up $372,075 (+16%) from 2013
Net Assets
Up$2,238,033
Up $255,381 (+13%) from 2013
Liabilities
Up$461,760
Up $116,694 (+34%) from 2013
Revenue And Expenses
Revenue
Down$2,597,285
Down $149,087 (-5.4%) from 2013
Expenses
Down$2,379,622
Down $110,005 (-4.4%) from 2013
Net Income
Down$217,663
Down $39,082 (-15%) from 2013
Historical Trend
Filing Detail Status
This 2014 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jul 1, 2013 to Jun 30, 2014
Mission and Program Overview
Mission
Casss sponsors international symposia for scientists in the biotechnology, pharmaceutical and academic arenas. Furthermore, casss provides educational, employment, and networking opportunities for its current members.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2014 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $2,699,793
- Liabilities
- $461,760
- Net assets
- $2,238,033
- Revenue
- $2,597,285
- Expenses
- $2,379,622
- Net income
- $217,663